#United States #Chicago #Colorectal Cancer #Health #WovenX

WovenX Health Creates a Nationwide GI Procedural Network

WovenX Health, a pioneering specialty care platform based in Chicago, has rolled out a comprehensive GI procedure partner network that spans across all 50 states, including Washington, D.C. This innovative initiative aims to enhance colorectal cancer screening processes by addressing significant care gaps, particularly for patients whose stool-based screening tests return positive results. The program is set to begin next month and focuses primarily on facilitating timely follow-up colonoscopies for patients in need.

A Vital Step in Cancer Prevention

Colorectal cancer remains a leading cause of cancer deaths in the United States. Early detection is crucial, and follow-up care after a positive screening result is essential for catching the disease at its earliest stages. Unfortunately, research, including a substantial study published in JAMA Network Open, indicates that over 48% of individuals who receive positive screening results do not follow through with the necessary colonoscopy within six months. With the intention of reducing this alarming statistic, WovenX's new procedural network aims to ensure that every positive screening result translates into a scheduled follow-up colonoscopy rather than a missed opportunity for care.

Dr. Russ Arjal, Co-Founder and Chief Medical Officer of WovenX Health, emphasizes the importance of this initiative: "Every patient who screens positive and doesn’t make it to a follow-up colonoscopy is a missed opportunity to catch disease early." To combat this issue, the company is creating a pathway that directly connects connecting patients with GI practices and health care systems equipped to provide the necessary follow-up.

The Functionality of the Network

Starting in 2027, health plans will be evaluated based on whether patients with positive stool screening tests successfully undergo follow-up colonoscopy, as outlined in a new HEDIS metric, the Follow-Up After Positive Colorectal Cancer Non-Invasive Screening Test. Therefore, it is imperative for health networks to effectively facilitate this follow-up care. The WovenX program offers patients navigation support when they receive a positive result, allowing them to select participating GI providers in their locality through a streamlined intake process that assesses their readiness for the procedure. This approach not only reduces the gap between test results and action but also optimizes patient outcomes.

Recognition and Inclusion for GI Practices

WovenX is also inviting gastrointestinal (GI) practices and health systems across the country to join its procedural partner network. Becoming a partner requires no financial commitment, and by joining, practices agree to prioritize the scheduling of follow-up colonoscopies. In return, they gain access to valuable pre-procedural intake information through the secure WovenX platform.

The company has garnered attention for its forward-thinking approach. It has recently been recognized as a quarterfinalist in the 2026 Digital Health AI Awards for its contribution to cancer screening and early detection while also receiving the Industry Disrupter Award at 1871's 19th Annual Momentum Awards.

About WovenX Health

Founded by a team led by Sheri Rudberg, Dr. Russ Arjal, and Nakort Valles Leon, WovenX Health is an AI-enhanced specialty care platform designed to connect patients swiftly to essential screenings and treatments without compromising the quality of clinical care. With its initial focus on gastroenterology, WovenX aims to release similar models across various specialties to improve access to timely and specialized healthcare. The platform's commitment to streamlining gastrointestinal care stems from personal experiences with healthcare delays among families and patients.

To learn more about WovenX Health and the new GI procedural network, visit www.wovenxhealth.com.